Cartilage repair is used to heal damaged cartilage surrounding joints, stiffness and ease pain, and regain joint mobility and function. According to BlueQuark the Global Cartilage Repair/ Cartilage Regeneration Market is expected to grow considerably during the forecasted period. Factors such as the growing incidence of bone and joint disorders, such as Osteoarthritis or arthritis, as well as advancements in cartilage regeneration technology, are expected to drive the Cartilage Repair/ Cartilage Regeneration Market in the forecasted period. Further, sports injuries, accidents, and a growing geriatric and obese populace are expected to drive the Cartilage Repair/ Cartilage Regeneration Market in the forecasted period. Furthermore, technological advancements and innovative treatment approaches are expected to drive the Cartilage Repair/ Cartilage Regeneration Market in the forecasted period. However, due to their high cost, cartilage repair therapies are undervalued compared to knee replacement surgeries, resulting in less preference for these procedures, which is expected to hinder the Cartilage Repair/ Cartilage Regeneration Market in the forecasted period.

A growing number of road accidents worldwide result in bone and joint injuries, expected to drive demand for cartilage repair products over the forecasted period. There is an increase in alcohol and reckless driving, the use of a mobile phone, and other associated factors such as bad weather and poor road construction. Cartilage repair is regenerating the cartilage surface of a joint damaged by a chondral defect or osteochondral. It may take months for swelling to lessen after an injury that causes an injury joint to enlarge. Due to its limited mitotic capacity and vascular structure, articular cartilage is damaged brought on by osteoarthritis and is less susceptible to repair. Symptoms of cartilage loss include physical impairment, soreness, stiffness, and inflammation of the muscles. An increase in the number of road accidents and sports-related injuries across the world, leading to bone and joint injuries, is predicted to amplify the requirement for cartilage repair procedures in forecasted periods. The recent technological advancements in cartilage regeneration procedures, coupled with the inception of new techniques in the market, prompted the adoption of cartilage repair and regeneration procedures in recent years. Sports injuries are one of the prominent drivers for the increasing adoption of cartilage repair procedures. Sports such as skating, bicycling, and skateboarding are significant sources of sports-related injuries. Articular cartilage, which acts as a cushion between bone terminals, is restored by cartilage regeneration. Bone collides with a bone when the cartilage is worn down, generating pain near the sensitive nerve ends. Due to cartilage lacking a blood supply, it cannot repair itself. The cartilage (articular) surface restoration of a joint that an osteochondral/chondral defect has impacted is referred to as cartilage repair. After an accident, the damaged joint typically swells up, and the swelling might take weeks or months to subside. Articular cartilage is a defect restored by Osteoarthritis, and due to its vascular structure and restricted mitotic capabilities, it is less critical for any repairs. Movement constraints, muscle stiffness, inflammation, soreness, and physical disability are cartilage loss symptoms.

North America holds most of the cartilage repair/regeneration market share. The primary growth driver of North America's cartilage repair/regeneration market is the increasing incidence of bone and joint disorders and the rising geriatric and obese population. The knee is the largest joint in the body, and most of the body weight goes through the knee when a person walks. Cartilage damage is a relatively common injury that often affects the knees. The knee segment is likely to grow over the forecast period due to increased knee replacements, knee implants, and the growing prevalence of Osteoarthritis. The cartilage repair market is classified into two major types based on treatment modalities are cell-based treatment and non-cell-based treatment. Cell-based treatment is considered one of the fastest-growing segments in the market, and it has generated substantial revenue in the last couple of years. The growing popularity of cell-based treatments is expected to provide wider growth opportunities for industry players. A considerable change has been observed in individuals' lifestyle and diet habits over the past two decades. Consumerism and urbanization are the primary reasons for this shift, leading to a high intake of artificial food products. Thus, the sedentary lifestyle and the lack of a balanced diet resulted in an increased incidence of obesity.

Being overweight increases the load exerted on joints, such as the knee, which causes tension and may speed up the breakdown of cartilage. Osteoarthritis is a condition where the cartilage in joints deteriorates, causing pain, stiffness, and reduced mobility. The non-cell-based segment is further categorized into tissue scaffolds and cell-free composites. Tissue scaffolds can promote the growth of cartilage and bone when transplanted into joints, particularly in the knees. As a result, they are more extensively utilized than cell-free composites. Two of the most treatments for Osteoarthritis are autologous chondrocyte implantation and scaffold implants. As a result, as the expansion of Osteoarthritis rises, so does the demand for cartilage regeneration.

The market key players are Osiris Therapeutics, Inc., Smith + Nephew, AlloSource, Vericel Corporation, and Zimmer Biomet.

In July 2022, Orthodox received Medicines and Healthcare Products Regulatory Agency (MHRA) authorisation for a clinical trial of knee cartilage repair FibroFix product platform.

Global Cartilage Repair/ Cartilage Regeneration Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Cartilage Repair/ Cartilage Regeneration Market by segmenting based on Type (Fibro Cartilage, Hyaline Cartilage, Elastic Cartilage, Other), Treatment Modality (Cell-Based, Non-Cell Based), Treatment Type (Palliative, Intrinsic Repair Stimulus), Application Site (Knee, Spine, Ankle, Hip, Others), Surgical Procedure (Chondroplasty and Microfracture, Autologous Chondrocyte Implantation, Osteochondral Autograft Transplantation, Osteochondral Allograft Transplantation, Juvenile Allograft Fragments, Others), End User Industry (Ambulatory Care Centers, Hospitals and Clinics, Surgical Centers, and Others), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East & Africa). The report examines the market drivers and restraints and the impact of COVID-19 on market growth in detail. The study covers emerging market trends, development, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects